Unichem Laboratories Limited (BOM:506690)
India · Delayed Price · Currency is INR 542.75
+3.95 (0.73%)
At close: Aug 17, 2026
Unichem Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 23,167 | 22,019 | 21,110 | 17,851 | 13,430 | 12,698 | |
Revenue Growth | 7.54% | 4.30% | 18.25% | 32.92% | 5.76% | 2.81% |
Cost of Revenue | 11,371 | 10,935 | 9,219 | 7,949 | 6,064 | 4,686 |
Gross Profit | 11,796 | 11,083 | 11,891 | 9,903 | 7,366 | 8,013 |
Selling, General & Admin | 4,073 | 4,114 | 4,208 | 4,263 | 3,690 | 3,468 |
Other Operating Expenses | 5,274 | 5,083 | 5,034 | 4,771 | 4,098 | 3,742 |
Operating Expenses | 10,580 | 10,448 | 10,488 | 10,265 | 8,922 | 8,122 |
Operating Income | 1,217 | 635.7 | 1,403 | -362.8 | -1,556 | -109.01 |
Interest Expense | -315.6 | -314.8 | -207 | -221.5 | -162.52 | -50.21 |
Interest & Investment Income | 53 | 53 | 28.5 | 6.7 | 5.22 | 164.91 |
Earnings From Equity Investments | - | - | - | - | - | -10.61 |
Currency Exchange Gain (Loss) | 454.3 | 454.3 | 215.6 | 224 | 273.16 | 273.82 |
Other Non Operating Income (Expenses) | 6.8 | 6.8 | 3.7 | -0.9 | -41.33 | -29.37 |
EBT Excluding Unusual Items | 1,415 | 835 | 1,444 | -354.5 | -1,481 | 239.53 |
Gain (Loss) on Sale of Investments | 95.5 | 95.5 | 92.6 | 64.7 | 90.49 | -17.49 |
Gain (Loss) on Sale of Assets | -25.3 | -25.3 | 9.5 | 16.3 | 12.83 | -2.34 |
Other Unusual Items | 2,019 | 2,019 | - | -576.1 | -385.66 | - |
Pretax Income | 3,504 | 2,924 | 1,546 | -849.6 | -1,764 | 219.69 |
Income Tax Expense | 456.1 | 395.4 | 170.7 | 88 | 258.65 | -110.93 |
Earnings From Continuing Operations | 3,048 | 2,528 | 1,375 | -937.6 | -2,022 | 330.62 |
Net Income | 3,048 | 2,528 | 1,375 | -937.6 | -2,022 | 330.62 |
Net Income to Common | 3,048 | 2,528 | 1,375 | -937.6 | -2,022 | 330.62 |
Net Income Growth | 143.86% | 83.86% | - | - | - | -3.68% |
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | 70 |
Shares Outstanding (Diluted) | 71 | 71 | 71 | 70 | 70 | 71 |
Shares Change | 0.32% | -0.13% | 0.31% | - | -0.25% | 0.25% |
EPS (Basic) | 43.27 | 35.91 | 19.53 | -13.32 | -28.72 | 4.70 |
EPS (Diluted) | 43.19 | 35.85 | 19.47 | -13.32 | -28.72 | 4.68 |
EPS Growth | 143.14% | 84.13% | - | - | - | -4.01% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,194 | -1,444 | -85.5 | -1,294 | -3,866 |
Free Cash Flow Per Share | - | -16.93 | -20.44 | -1.21 | -18.38 | -54.78 |
Dividend Per Share | - | - | - | - | - | 4.000 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 50.92% | 50.34% | 56.33% | 55.47% | 54.85% | 63.10% |
Operating Margin | 5.25% | 2.89% | 6.65% | -2.03% | -11.58% | -0.86% |
Profit Margin | 13.16% | 11.48% | 6.51% | -5.25% | -15.06% | 2.60% |
Free Cash Flow Margin | - | -5.42% | -6.84% | -0.48% | -9.63% | -30.45% |
EBITDA | 2,397 | 1,815 | 2,577 | 810.7 | -480.19 | 747.05 |
EBITDA Margin | 10.35% | 8.24% | 12.21% | 4.54% | -3.57% | 5.88% |
D&A For EBITDA | 1,181 | 1,179 | 1,174 | 1,174 | 1,076 | 856.06 |
EBIT | 1,217 | 635.7 | 1,403 | -362.8 | -1,556 | -109.01 |
EBIT Margin | 5.25% | 2.89% | 6.65% | -2.03% | -11.58% | -0.86% |
Effective Tax Rate | 13.02% | 13.52% | 11.04% | - | - | - |
Revenue as Reported | 23,797 | 22,649 | 21,463 | 18,167 | 13,815 | 13,173 |
Advertising Expenses | - | 123.1 | 168.2 | 215.2 | 117.46 | 144.12 |